Caricamento...
Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy
Advanced melanoma remains a disease with poor prognosis. Several serologic markers have been investigated to help monitoring and prognostication, but to date only lactate dehydrogenase (LDH) has been validated as a standard prognostic factor biomarker for this disease by the American Joint Committee...
Salvato in:
| Pubblicato in: | Sci Rep |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group UK
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7198615/ https://ncbi.nlm.nih.gov/pubmed/32366871 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-63441-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|